Skip to main content

Cardiorespiratory Assessment at the Point of Care

Improve treatment and diagnostic decisions with fast, accurate, and non-invasive assessments of cardiorespiratory status using the MediPines AGM100™

head

Fast

Results in under two minutes

head

Accurate

O2 and CO2  gas levels from the lungs sampled at rest

head

Painless

Non-Invasive: resting breath sampling with no needles 

AGM100: Oxygenation, Ventilation, and Gas Exchange Measurements in One Breathing Session

Essential Clinical Insights, Non-Invasively Delivered Instantly at the Point-of-Care

background-video-mp

Pulmonary gas exchange is critical for our health- as shown in the lungs' tiny alveoli. Here, oxygen is absorbed into the blood, and carbon dioxide is released to be exhaled. This natural process of gas movement in the body, called diffusion,  occurs in 500 million alveoli and ensures our blood is oxygen-rich for circulation.

The AGM100 technology leverages this principle, monitoring gas levels directly with advanced sensors combined with computational means to enhance precision to aid in assessing patients' respiratory and cardiovascular health.  Vital clinical information, such as blood oxygenation, ventilation and gas exchange, that traditionally required time-consuming invasive procedures is now available at the point-of-care with the AGM100. 

  • Gas Exchange

    Assessing respiratory impairment in patients is a critical aspect of clinical management. Traditionally, the Riley method (A-a gradient) has been the gold standard measure for gas exchange efficiency, but this approach...

    Read more


  • Clinical Accuracy

    Clinicians know that unlike other tests, the AGM100 provides accurate measurements of gas exchange impairment to differentiate healthy and sick patients...

    Read more


     

  • Operational Efficiency

    Patients in respiratory distress require immediate medical attention. The ability to quickly identify hypoxemia is crucial...

    Read more

One device, multiple measurements

agm100-devicefront

Clinicians using the AGM100 can compress the time to diagnosis and treatment decision throughout a patient's care continuum.  

  • Oxygenation
  • Ventilation
  • Gas exchange impairment
  • Diffusion limitations
  • Low inspired oxygen

Manage patients for positive health outcomes

Broad applicability from hospitals to clinics 

ER/Critical Care

 

Pulmonology

 

Cardiology

 

Anesthesiology

  • Immediately identify respiratory impairment at the point of care
  • Support diagnosis and treatment decisions from chronic to acute cases
  • Confirm treatment effectiveness with a high degree of objectivity
  • Verify worsening/improving cardiorespiratory conditions 
  • Risk stratify patients before and after surgical procedure 

MediPines AGM100

Industry Coverage

who logo

Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured...

DR MARIÂNGELA SIMÃO
WHO Assistant Director General

 

la business journal logo

“The AGM100 is already playing a crucial role in respiratory assessment and treatment in a quickly growing number of hospitals across the nation."

LOS ANGELES BUSINESS JOURNAL

pictures-11

“These winners represent some of the most promising emerging medical device innovations in the diagnosis, treatment, and care of children affected..."

PAUL GRAND
CEO of MedTech Innovator

News

MediPines Announces New Reimbursement Code for Non-Invasive Assessment of Cardiorespiratory Status by the AGM100

New AMA CPT® Code Establishes Pathway For Clinicians To Submit Claims For Use Of MediPines AGM100®

MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the "Make Your Medical Device Pitch for Kids!" competition presented by ...

UCSD Distinguished Lecture Series

UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza August 02, 2023 11:57 AM Eastern Daylight Time MediPines, ...

Medscape Interview Highlights MediPines AGM100’s 99% Accuracy for Emergency Room Oxygen Therapy Decisions in COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology ...

Medipines Featured in Los Angeles Business Journal

Innovative Technology Detects Respiratory Impairment Respiratory impairment detection has long been a diagnostic “blind spot,” with the traditional tools available causing ...

Emergency Department Study Demonstrates Utility of MediPines AGM100 in Triaging COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a study presented at the American Thoracic Society (ATS) International Conference 2022, the MediPines AGM100 was shown to provide data that ...

Physicians Use MediPines Non-Invasive Gas-Exchange Analyzer Technology to Assist with Differential Diagnosis for Pulmonary Embolism

YORBA LINDA, Calif., May 24, 2022–(BUSINESS WIRE)–An increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and ...

MediPines Adds Three Global Thought Leaders to its Medical and Scientific Advisory Board

March 01, 2022 12:04 PM Eastern Standard Time YORBA LINDA, Calif.–(BUSINESS WIRE)–Orange County, California based MediPines Corporation, a market leader in the development of gas ...

World Health Organization Recognizes MediPines AGM100® in 2021 Compendium for Innovative Health Technologies

ORANGE COUNTY, Calif., Sept. 21, 2021 /CNW/ — The World Health Organization (WHO) has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology ...

MediPines AGM100® – Medical Design Excellence 2021 Award Winner

MediPines is pleased to announce that their AGM100® device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence ...

MediPines AGM100® Gas Exchange Measurements Validated Against ABGs (Arterial Blood Gases)

Study Published in CHEST Validates MediPines AGM100® Non-invasive Pulmonary Gas Exchange Measurements with Arterial Blood Gases Under Hypoxic Conditions ORANGE COUNTY, Calif., May ...

MediPines Obtains International MDSAP ISO 13485 Medical Device Certification

ORANGE COUNTY, Calif., April 9, 2020 /PRNewswire/ — MediPines Corporation announces that it received the Medical Device Single Audit Program certification, MDSAP ISO 13485:2016 ...

FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study

Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida PR Newswire ORANGE COUNTY, Calif., April 12, 2019 ...

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the ...